EGFR and breast cancer: Induction of unfolded protein response and apoptosis in neuroblastoma [69]; inhibits LPS-activated, Akt-mediated activation of NF-κB in macrophages [70]. Anti-tumor activity through EGFR pathway suppression in breast cancer cells [71]. Shown to inhibit Hsp90 [72].